Problem-solving
There's a lot we don't know about psychedelic medicine - in any species, human or veterinary...yet. The discoveries emerging from the human-side of medicine are ground-breaking.
​
What does this mean for animal species? We're asking those questions.
​
Veterinary medicine is in need of novel medical solutions to combat the behavioral conditions rampant in veterinary species. As psychedelic substances make headlines as novel and effective medicines for human behavioral conditions, animal caregivers and veterinary professionals alike are curious if these modalities can provide healing to animal patients as well.
Current Projects
-
Survey: animal exposures to psychoactive substances​
-
The effect of cannabinoids in working animals: diabetic alert dogs (DAD)
Upcoming Projects
​
-
Therapeutic potential of MDMA in canine post-traumatic stress disorder (cPTSD)
-
Therapeutic potential of MDMA in behavior disorders of animal victims of sexual abuse
-
Therapeutic potential of psilocybin in end-of-life support for bonded animal-human pairs
In the Media
-
Exploring the Evolutionary, Developmental, and Therapeutic Effects of MDMA in Animals Dr. Casara Andre participates in this Care for the Healer, One Health Discovery Series episode with Dr. Gül Dölen. The discussion explores Dr. Dölen's research related to the use of 3-4-methylenedioxymethamphetamine (MDMA) in rodents and octopuses and the consistent pro-social effects of MDMA across species with vastly different neurological systems.
​
-
Past, Present, and Future of Psychedelic Assisted Therapy in Humans and Animals - As decriminalization of psychedelic substances steadily progresses, how do medical practitioners navigate harm reduction for patients of all species and guard against accidental or medically-inappropriate use? Dr. Casara Andre joins PhD historian, Erika Dyck, and medical anthropologist, Jessica Cadoch to explore the One Health intersections of psychedelic-assisted therapies in both human and veterinary patients.
​
​